Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Kearns?Sayre Syndrome is a rare, progressive genetic disorder that affects the body's energy production systems. It is classified as a mitochondrial disease, primarily causing weakness in the eye muscles, heart conduction defects, and neurological problems.
read more about kearnssayre syndrome ...The cause involves large-scale deletions in the mitochondrial DNA. Mitochondria are the organelles responsible for generating energy (ATP) in cells; the genetic defect prevents cells from producing sufficient energy to maintain function, especially in high-energy organs like the eyes, heart, and brain. This lack of energy causes muscle fibers to degenerate and fail. The disease is sporadic in most cases, meaning it is not inherited but arises from a new mutation.
Symptoms are defined by three distinct features: ophthalmoplegia (paralysis of eye movement), ptosis (droopy eyelids), and cardiac conduction defects (abnormal heart rhythm). The severe drooping of the eyelids and the inability to move the eyes fully are typically the first signs noticed by patients.2 The heart defect can be life-threatening, requiring constant monitoring.3 Patients also experience muscle weakness and ataxia (poor coordination), which worsens over time.</
Kearns?Sayre Syndrome severely impacts eye health, as external ophthalmoplegia is a hallmark symptom. The muscles controlling eye movement become paralyzed, causing fixed gaze. The disease also causes retinopathy (pigment changes in the retina), leading to poor vision in low light and progressive visual field loss.
Diagnosis involves a muscle biopsy, which shows characteristic "ragged-red fibers" (damaged mitochondria) under a microscope. Genetic testing confirms the mtDNA deletion. An electrocardiogram ECG is necessary to check for cardiac conduction defects.
Necessary treatments focus on managing the systemic complications. There is no cure, but medications are used to manage heart rhythm. Patients with cardiac defects often require a pacemaker. Ptosis can be treated surgically, and vision aids may be needed for severe vision loss.
No, the condition is usually sporadic, meaning it is a new mutation in the individual.
Yes, the cardiac conduction defects are life-threatening and are the most serious risk associated with the syndrome.
No, the muscle weakness is progressive and usually irreversible.
Consult a neuro-ophthalmologist for "Chronic Progressive External Ophthalmoplegia" (CPEO), a slow loss of eye movement. KSS is a mitochondrial disease characterized by a "Salt and Pepper" retina. Patients require a pacemaker to prevent sudden cardiac death from heart block.
Consult a neuro-ophthalmologist for "Chronic Progressive External Ophthalmoplegia" (CPEO), a slow loss of eye movement. KSS is a mitochondrial disease characterized by a "Salt and Pepper" retina. Patients require a pacemaker to prevent sudden cardiac death from heart block.